Bringing the fundamentals into focus…
Back to Mirum Pharmaceuticals, Inc.
How Mirum Pharmaceuticals, Inc. stacks up
MIRM · against 219 other Healthcare companies of similar size
Profitability
13/ 100
Near the bottom of its peers.
Ranked #198 of 220 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score16 peers with a profitability score of 10–19, including MIRM · Click a bar to see the companies
Why profitability scores 13?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 97% of peers. Return on assets: -82.3% vs peer median 1.7%
- a thinner operating margin: weaker than 88% of peers. Operating margin: -134.9% vs peer median 7.1%
- a lower return on invested capital: weaker than 80% of peers. Return on invested capital: -23.0% vs peer median 4.7%
Metric by metric
Position: dot = MIRM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MIRM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 212 reported | -23.0% | 8.2% | 15% | 33% | |
| Operating marginHigher is better · 201 reported | -134.9% | 10.9% | 8% | 33% | |
| Return on assetsHigher is better · 210 reported | -82.3% | 3.3% | 1% | 33% | |
| Return on equityHigher is better · 205 reported | -703.0% | 7.7% | 1% | Context only | |
| Gross marginHigher is better · 229 reported | 81.7% | 49.5% | 89% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around MIRM| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 3.8B USD | 99 | 71 | |
| 4 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 4 | 170.4B THB (≈$4.8B) | 98 | 70 | |
| 194 | 4.0B USD | 16 | 30 | |
| 194 | 6.0B USD | 16 | 32 | |
| 197 | 5.4B USD | 15 | 38 | |
| 198 | 3.7B USD | 13 | 31 | |
| 198 | 5.7B USD | 13 | 30 | |
| 198 | 3.9B USD | 13 | 52 | |
| 201 | 3.4B USD | 12 | 35 | |
| 201 | 5.1B USD | 12 | 35 | |
| 201 | 10.5B USD | 12 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score